nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—SHBG—polycystic ovary syndrome	0.784	1	CbGaD
Equilin—HSD17B1—Estrogen biosynthesis—CYP19A1—polycystic ovary syndrome	0.0306	0.176	CbGpPWpGaD
Equilin—HSD17B1—Steroid Biosynthesis—HSD3B1—polycystic ovary syndrome	0.0163	0.0941	CbGpPWpGaD
Equilin—HSD17B1—Steroid Biosynthesis—HSD3B2—polycystic ovary syndrome	0.0145	0.0838	CbGpPWpGaD
Equilin—HSD17B1—female gonad—polycystic ovary syndrome	0.0109	0.291	CbGeAlD
Equilin—HSD17B1—Steroid Biosynthesis—CYP17A1—polycystic ovary syndrome	0.0107	0.0615	CbGpPWpGaD
Equilin—HSD17B1—endocrine gland—polycystic ovary syndrome	0.0102	0.271	CbGeAlD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—SRD5A1—polycystic ovary syndrome	0.00774	0.0446	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—STAR—polycystic ovary syndrome	0.00738	0.0426	CbGpPWpGaD
Equilin—HSD17B1—The canonical retinoid cycle in rods (twilight vision)—RBP4—polycystic ovary syndrome	0.00689	0.0398	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—HSD3B1—polycystic ovary syndrome	0.00627	0.0362	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—LHB—polycystic ovary syndrome	0.00572	0.033	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.00559	0.0323	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.00442	0.0255	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—GNRH1—polycystic ovary syndrome	0.00427	0.0246	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.0041	0.0237	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—CYP19A1—polycystic ovary syndrome	0.00325	0.0187	CbGpPWpGaD
Equilin—SHBG—endometrium—polycystic ovary syndrome	0.00244	0.0651	CbGeAlD
Equilin—SHBG—Nongenotropic Androgen signaling—AR—polycystic ovary syndrome	0.00241	0.0139	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—AKR1C1—polycystic ovary syndrome	0.00232	0.0134	CbGpPWpGaD
Equilin—SHBG—uterus—polycystic ovary syndrome	0.00225	0.0599	CbGeAlD
Equilin—SHBG—pituitary gland—polycystic ovary syndrome	0.00221	0.0589	CbGeAlD
Equilin—SHBG—adipose tissue—polycystic ovary syndrome	0.0022	0.0586	CbGeAlD
Equilin—HSD17B1—Diseases associated with visual transduction—RBP4—polycystic ovary syndrome	0.00214	0.0123	CbGpPWpGaD
Equilin—SHBG—adrenal gland—polycystic ovary syndrome	0.00197	0.0526	CbGeAlD
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.00195	0.0113	CbGpPWpGaD
Equilin—SHBG—female gonad—polycystic ovary syndrome	0.00184	0.049	CbGeAlD
Equilin—SHBG—vagina—polycystic ovary syndrome	0.00183	0.0487	CbGeAlD
Equilin—HSD17B1—Diseases associated with visual transduction—AKR1C3—polycystic ovary syndrome	0.00179	0.0103	CbGpPWpGaD
Equilin—SHBG—endocrine gland—polycystic ovary syndrome	0.00171	0.0456	CbGeAlD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00126	0.00728	CbGpPWpGaD
Equilin—Estriol—SHBG—polycystic ovary syndrome	0.00126	0.255	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000998	0.00576	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000998	0.00576	CbGpPWpGaD
Equilin—Estropipate—SHBG—polycystic ovary syndrome	0.000962	0.195	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000836	0.00482	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000793	0.00457	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000756	0.00436	CbGpPWpGaD
Equilin—HSD17B1—Disease—NMNAT3—polycystic ovary syndrome	0.000734	0.00423	CbGpPWpGaD
Equilin—Ethinyl Estradiol—SHBG—polycystic ovary syndrome	0.000687	0.14	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000678	0.00391	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000678	0.00391	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000643	0.00371	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000615	0.00355	CbGpPWpGaD
Equilin—Estrone—SHBG—polycystic ovary syndrome	0.000599	0.122	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000587	0.00338	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000573	0.00331	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000562	0.00324	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SUOX—polycystic ovary syndrome	0.000562	0.00324	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000555	0.0032	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000523	0.00302	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000511	0.00295	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000477	0.00275	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00047	0.00271	CbGpPWpGaD
Equilin—Estradiol—SHBG—polycystic ovary syndrome	0.000454	0.0921	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000453	0.00261	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000445	0.00256	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TEAD2—polycystic ovary syndrome	0.000445	0.00256	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000427	0.00247	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000421	0.00243	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000411	0.00237	CbGpPWpGaD
Equilin—Estradiol—AR—polycystic ovary syndrome	0.000398	0.0808	CrCbGaD
Equilin—HSD17B1—Disease—RPL37A—polycystic ovary syndrome	0.000378	0.00218	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000372	0.00215	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000372	0.00214	CbGpPWpGaD
Equilin—HSD17B1—Disease—HMMR—polycystic ovary syndrome	0.000359	0.00207	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000353	0.00204	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000343	0.00198	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000343	0.00198	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—STAR—polycystic ovary syndrome	0.000337	0.00194	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000333	0.00192	CbGpPWpGaD
Equilin—Estrone—CYP1A1—polycystic ovary syndrome	0.000323	0.0656	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000321	0.00185	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000311	0.0018	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000303	0.00175	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HMMR—polycystic ovary syndrome	0.0003	0.00173	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000295	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKR1C1—polycystic ovary syndrome	0.000295	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000286	0.00165	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000283	0.00163	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000276	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF18—polycystic ovary syndrome	0.000274	0.00158	CbGpPWpGaD
Equilin—HSD17B1—Disease—RBP4—polycystic ovary syndrome	0.000272	0.00157	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000268	0.00155	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LHB—polycystic ovary syndrome	0.000261	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000255	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000251	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Disease—GAB1—polycystic ovary syndrome	0.00025	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000247	0.00143	CbGpPWpGaD
Equilin—Estradiol—CYP1A1—polycystic ovary syndrome	0.000245	0.0497	CrCbGaD
Equilin—HSD17B1—Disease—NAMPT—polycystic ovary syndrome	0.000244	0.00141	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000236	0.00136	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00023	0.00132	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000228	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKR1C3—polycystic ovary syndrome	0.000227	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FST—polycystic ovary syndrome	0.000224	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Disease—TNRC6B—polycystic ovary syndrome	0.000224	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000221	0.00127	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—RRM2—polycystic ovary syndrome	0.00022	0.00127	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000218	0.00126	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000213	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—YAP1—polycystic ovary syndrome	0.000212	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000207	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000205	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NAMPT—polycystic ovary syndrome	0.000204	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000203	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000202	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.0002	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000195	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000192	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Disease—TCF7L2—polycystic ovary syndrome	0.000192	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKR1C3—polycystic ovary syndrome	0.00019	0.0011	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00019	0.0011	CbGpPWpGaD
Equilin—HSD17B1—Disease—SLC2A4—polycystic ovary syndrome	0.000188	0.00109	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000187	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRL—polycystic ovary syndrome	0.00018	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000178	0.00102	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000175	0.00101	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000168	0.000966	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TH—polycystic ovary syndrome	0.000162	0.000935	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000159	0.000918	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000158	0.00091	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000157	0.000904	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000155	0.000895	CbGpPWpGaD
Equilin—HSD17B1—Disease—NCOR1—polycystic ovary syndrome	0.000151	0.000868	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000148	0.000855	CbGpPWpGaD
Equilin—HSD17B1—Disease—NRG1—polycystic ovary syndrome	0.000148	0.000852	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000144	0.000832	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000144	0.000832	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000138	0.000793	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000134	0.000774	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTHFR—polycystic ovary syndrome	0.000133	0.000768	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GNAS—polycystic ovary syndrome	0.000132	0.000764	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000127	0.000732	CbGpPWpGaD
Equilin—HSD17B1—Disease—IRS2—polycystic ovary syndrome	0.000127	0.00073	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOR1—polycystic ovary syndrome	0.000126	0.000727	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000126	0.000726	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1A1—polycystic ovary syndrome	0.00012	0.00069	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000119	0.000689	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTHFR—polycystic ovary syndrome	0.000111	0.000643	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000111	0.000638	CbGpPWpGaD
Equilin—HSD17B1—Disease—IRS1—polycystic ovary syndrome	0.000111	0.000637	CbGpPWpGaD
Equilin—HSD17B1—Disease—INS—polycystic ovary syndrome	0.000106	0.00061	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000105	0.000608	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000103	0.000597	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT2—polycystic ovary syndrome	0.000102	0.00059	CbGpPWpGaD
Equilin—HSD17B1—Disease—SERPINE1—polycystic ovary syndrome	9.72e-05	0.000561	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARG—polycystic ovary syndrome	9.04e-05	0.000521	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—POMC—polycystic ovary syndrome	8.91e-05	0.000514	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IRS2—polycystic ovary syndrome	8.86e-05	0.000511	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—INS—polycystic ovary syndrome	8.86e-05	0.000511	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEP—polycystic ovary syndrome	8.67e-05	0.0005	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.74e-05	0.000446	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—POMC—polycystic ovary syndrome	7.45e-05	0.00043	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—INS—polycystic ovary syndrome	7.41e-05	0.000427	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—polycystic ovary syndrome	7.17e-05	0.000413	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT2—polycystic ovary syndrome	7.16e-05	0.000413	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.81e-05	0.000393	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.68e-05	0.00027	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—polycystic ovary syndrome	4.62e-05	0.000267	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—polycystic ovary syndrome	3.24e-05	0.000187	CbGpPWpGaD
